Update on Medullary Thyroid Cancer

被引:27
作者
Hu, Mimi I. [1 ]
Ying, Anita K. [1 ]
Jimenez, Camilo [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA
关键词
Medullary thyroid carcinoma; MEN type 2; Pathophysiology; Diagnosis; Treatment; GROWTH-FACTOR RECEPTOR; POSITRON-EMISSION-TOMOGRAPHY; FINE-NEEDLE-ASPIRATION; RET PROTOONCOGENE MUTATIONS; DENDRITIC CELL VACCINATION; ANTIGEN DOUBLING-TIMES; PHASE-II TRIAL; PROGNOSTIC-FACTORS; TYROSINE KINASE; SOMATIC MUTATIONS;
D O I
10.1016/j.ecl.2014.02.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Medullary thyroid carcinoma (MTC) is a rare type of thyroid cancer, demonstrating variable behavior from indolent disease to highly aggressive, progressive disease. There are distinguishing phenotypic features of sporadic and hereditary MTC. Activation or overexpression of cell surface receptors and up-regulation of intracellular signaling pathways in hereditary and sporadic MTC are involved in the disease pathogenesis. There has been an exponential rise in clinical trials with investigational agents, leading to approval of 2 medications for progressive, advanced MTC. Developments in understanding the pathogenesis of MTC will hopefully lead to more effective and less toxic treatments of this rare but difficult to treat cancer.
引用
收藏
页码:423 / +
页数:21
相关论文
共 116 条
[1]   Medullary Thyroid Carcinoma: Long-Term Outcomes of Surgical Treatment [J].
Abraham, Deepak T. ;
Low, Tsu-Hui ;
Messina, Marinella ;
Jackson, Nicole ;
Gill, Anthony ;
Chou, Angela S. ;
Delbridge, Leigh ;
Learoyd, Diana ;
Robinson, Bruce G. ;
Sidhu, Stan ;
Sywak, Mark .
ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (01) :219-225
[2]   Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations in RET and RAS [J].
Agrawal, Nishant ;
Jiao, Yuchen ;
Sausen, Mark ;
Leary, Rebecca ;
Bettegowda, Chetan ;
Roberts, Nicholas J. ;
Bhan, Sheetal ;
Ho, Allen S. ;
Khan, Zubair ;
Bishop, Justin ;
Westra, William H. ;
Wood, Laura D. ;
Hruban, Ralph H. ;
Tufano, Ralph P. ;
Robinson, Bruce ;
Dralle, Henning ;
Toledo, Sergio P. A. ;
Toledo, Rodrigo A. ;
Morris, Luc G. T. ;
Ghossein, Ronald A. ;
Fagin, James A. ;
Chan, Timothy A. ;
Velculescu, Victor E. ;
Vogelstein, Bert ;
Kinzler, Kenneth W. ;
Papadopoulos, Nickolas ;
Nelkin, Barry D. ;
Ball, Douglas W. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (02) :E364-E369
[3]   The GDNF family: Signalling, biological functions and therapeutic value [J].
Airaksinen, MS ;
Saarma, M .
NATURE REVIEWS NEUROSCIENCE, 2002, 3 (05) :383-394
[4]   68Ga-somatostatin analogues PET and 18F-DOPA PET in medullary thyroid carcinoma [J].
Ambrosini, Valentina ;
Marzola, Maria Cristina ;
Rubello, Domenico ;
Fanti, Stefano .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (01) :46-48
[5]   Molecular modeling of the extracellular domain of the RET receptor tyrosine kinase reveals multiple cadherin-like domains and a calcium-binding site [J].
Anders, J ;
Kjær, S ;
Ibáñez, CF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (38) :35808-35817
[6]   Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators [J].
Ayala-Ramirez, Montserrat ;
Feng, Lei ;
Johnson, Marcella M. ;
Ejaz, Shamim ;
Habra, Mouhammed Amir ;
Rich, Thereasa ;
Busaidy, Naifa ;
Cote, Gilbert J. ;
Perrier, Nancy ;
Phan, Alexandria ;
Patel, Shreyaskumar ;
Waguespack, Steven ;
Jimenez, Camilo .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (03) :717-725
[7]   Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma [J].
Bachleitner-Hofmann, Thomas ;
Friedl, Josef ;
Hassler, Michaela ;
Hayden, Hubert ;
Dubsky, Peter ;
Sachet, Monika ;
Rieder, Erwin ;
Pfragner, Roswitha ;
Brostjan, Christine ;
Riss, Stefan ;
Niederle, Bruno ;
Gnant, Michael ;
Stift, Anton .
ONCOLOGY REPORTS, 2009, 21 (06) :1585-1592
[8]   Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma [J].
Barbet, J ;
Campion, L ;
Kraeber-Bodéré, F ;
Chatal, JF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (11) :6077-6084
[9]  
Baudin E, 1996, J NUCL MED, V37, P912
[10]   The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT [J].
Beheshti, Mohsen ;
Poecher, Sigrid ;
Vali, Reza ;
Waldenberger, Peter ;
Broinger, Gabriele ;
Nader, Michael ;
Kohlfuerst, Susanne ;
Pirich, Christian ;
Dralle, Henning ;
Langsteger, Werner .
EUROPEAN RADIOLOGY, 2009, 19 (06) :1425-1434